CSA Neuroprotection Study: AMPK/Nrf2 Pathway Activation in Ischemic Stroke Models

A research dataset from Hui Xu at the University of Hong Kong investigates the neuroprotective effect of Cajaninstilbene acid (CSA) against cerebral ischemia and reperfusion damage. The study uses in vitro oxygen and glucose deprivation/reoxygenation (OGD/R) models in SH-SY5Y cells and in vivo transient middle cerebral artery occlusion/reperfusion (MCAO/R) models in rats. It analyzes the molecular mechanism via the AMPK/Nrf2 pathway using Western blotting and inhibitor blocking.

Use Cases

• Modeling neuroprotective drug efficacy based on cell death and infarct volume reduction data.
• Analyzing molecular signaling pathways based on AMPK and Nrf2 activation measurements.
• Studying oxidative stress and mitochondrial dysfunction in ischemic stroke models.
• Evaluating potential drug candidates for ischemic stroke treatment based on preclinical experimental results.

Strengths

• Data is derived from both in vitro (SH-SY5Y cells) and in vivo (rat MCAO/R model) experimental approaches.
• Study includes specific molecular pathway analysis (AMPK/Nrf2) using Western blotting and pharmacological inhibitors.
• Results include concrete outcome measures such as reduced cell death, decreased infarct volume, and improved neurological deficits.

Limitations

• Row count and specific column-level documentation are absent; field semantics must be inferred after download.
• Data scale is unknown, which may limit suitability assessment for large-scale ML tasks.
• Freshness is unverified as the last update date is unknown.

Provenance

Source

University of Hong Kong

Collection Method

Experimental data from laboratory studies using cell culture and animal models.